Summary: H.R.19 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.19. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (12/09/2019)

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit,
  • modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
  • revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.